Status:
COMPLETED
Study In Adults And Adolescents With Seasonal Allergic Rhinitis
Lead Sponsor:
GlaxoSmithKline
Conditions:
Hayfever
Rhinitis, Allergic, Seasonal
Eligibility:
All Genders
12+ years
Phase:
PHASE3
Brief Summary
The purpose of the study is to compare the efficacy and safety of an investigational nasal spray compared with placebo nasal spray in the treatment of seasonal allergic rhinitis. Allergic rhinitis is ...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Informed consent.
- Outpatient.
- Females must use appropriate contraception.
- Diagnosis of seasonal allergic rhinitis.
- Adequate exposure to allergen.
- Able to comply with study procedures.
- Literate.
- Exclusion criteria:
- Significant concomitant medical condition.
- Use of corticosteroids, allergy medications, or tobacco.
- Clinically significant abnormal ECG.
- Laboratory abnormality.
- Positive pregnancy test.
- Allergy to any component of the investigational product.
Exclusion
Key Trial Info
Start Date :
December 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2005
Estimated Enrollment :
304 Patients enrolled
Trial Details
Trial ID
NCT00115622
Start Date
December 1 2004
End Date
January 1 2005
Last Update
September 1 2016
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
GSK Investigational Site
Austin, Texas, United States, 78731
2
GSK Investigational Site
Austin, Texas, United States, 78759
3
GSK Investigational Site
New Braunfels, Texas, United States, 78130
4
GSK Investigational Site
San Antonio, Texas, United States, 78229